NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Mark Day
University of Michigan - Ann Arbor / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1290042
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Mark Day's MOST POPULAR ARTICLES
1-)
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma The American journal of pathology 147 (2), 386, 1995
2-)
E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology Human pathology 32 (7), 690-697, 2001
3-)
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab Cancer research 73 (5), 1635-1646, 2013
4-)
E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology, Human pathology 32 (7), 690-697, 2001
5-)
HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab, Cancer research 73 (5), 1635-1646, 2013
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept